Pretty sure all this company does anymore is issue their own directors shares. If yinz remember that’s exactly what I said was going to happen with the RS. People argued with me on here saying, “Brady’s shares will be shortened as well”. Ya but they just issue themselves more shares. Oh well... hope they eventually get through clinical on into them. Be honest I don’t even know where they are at at this point.
Market Data 
Markets 
AI
